Bortezomib (BZB)-associated adverse events (AE) in patients with multiple myeloma (MM).
L. Katragadda
No relevant relationships to disclose
N. Sanathkumar
No relevant relationships to disclose
M. Veeraputhiran
No relevant relationships to disclose
A. Restrepo
No relevant relationships to disclose
S. Haider
No relevant relationships to disclose
J. Muzaffar
No relevant relationships to disclose
B. Barlogie
Research Funding - Celgene; Millennium
E. J. Anaissie
No relevant relationships to disclose